BioCentury
ARTICLE | Finance

Ebb & Flow

April 5, 2004 7:00 AM UTC

Private investors continued their love affair with the life sciences, as Alta Partners raised $475 million for two funds last week, and - in a slight change of direction - all of the money will go to the life sciences.

When the firm started marketing the funds last year, it had planned to raise a later-stage biotech fund and a diversified IT early-stage biotech fund. But based on the response from investors, Alta changed the planned diversified fund to an early- stage biotech fund, according to general partner Farah Champsi. ...